Labeled myo-Inositol Trispyrophosphate hexasodium. A novel membrane-permeant allosteric effector of hemoglobin (Hb), enhances the regulated oxygen release capacity of red blood cells, thus counteracting the effects of hypoxia in diseases such as cancer and cardiovascular ailments. Melting Point: As Reported Solubility: As Reported Atmosphere: Inert Gas Method for Determining Identity: Proton 31P NMR (DMSO-d6) and Mass Spectrometric Analysis TLC Conditions: As Reported Sodium Content: As Reported Water Content: As Reported Normalized Intensity: As Reported Storage and Stability: May be stored at RT for short-term only. Long-term storage is recommended at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Hygroscopic. Store under inert atmosphere. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.
Molecular Weight:
743.92
Purity:
~90%
* VAT and and shipping costs not included. Errors and price changes excepted
